Jin Medical International Ltd. financial data

Symbol
ZJYL on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, China
State of incorporation
Cayman Islands
Fiscal year end
September 30
Latest financial report
Q3 2023 - Apr 26, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Operating Margin 14.5 % +30.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 156M shares
Common Stock, Shares, Outstanding 156M shares +15.5%
Common Stock, Value, Issued 7.8K USD +15.5%
Weighted Average Number of Shares Outstanding, Basic 145M shares +7.51%
Weighted Average Number of Shares Outstanding, Diluted 146M shares +7.85%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 19.8M USD +3.29%
Cost of Revenue 13M USD +0.34%
Research and Development Expense 1.54M USD -18.5%
General and Administrative Expense 1.92M USD +8.34%
Operating Income (Loss) 2.87M USD +34.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.22M USD +17.5%
Income Tax Expense (Benefit) 344K USD +852%
Net Income (Loss) Attributable to Parent 2.88M USD +6.34%
Earnings Per Share, Basic 0.02 USD/shares 0%
Earnings Per Share, Diluted 0.02 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 3.28M USD -14.3%
Inventory, Net 5.05M USD -24.9%
Assets, Current 31.1M USD +64.6%
Deferred Income Tax Assets, Net 152K USD -37.8%
Property, Plant and Equipment, Net 1.48M USD -9.04%
Operating Lease, Right-of-Use Asset 154K USD -5.42%
Assets 32.9M USD +57.1%
Accounts Payable, Current 3.39M USD -17.6%
Liabilities, Current 8.92M USD +56.5%
Liabilities 8.92M USD +56.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.4M USD -54.1%
Retained Earnings (Accumulated Deficit) 16.9M USD +17.5%
Stockholders' Equity Attributable to Parent 24M USD +57.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 24M USD +57.4%
Liabilities and Equity 32.9M USD +57.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.11M USD +96.5%
Net Cash Provided by (Used in) Financing Activities 6.91M USD +5571%
Net Cash Provided by (Used in) Investing Activities -7.73M USD -6294%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 156M shares +15.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.14M USD +90.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.93M USD +44.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 143K USD +201%
Deferred Tax Assets, Valuation Allowance 15.7K USD +10.1%
Deferred Tax Assets, Gross 168K USD -35.2%
Depreciation 221K USD -38.2%
Payments to Acquire Property, Plant, and Equipment 114K USD +184%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2.38M USD +97.6%
Lessee, Operating Lease, Liability, to be Paid 7.12K USD
Property, Plant and Equipment, Gross 5.24M USD -0.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 165 USD
Lessee, Operating Lease, Liability, to be Paid, Year One 4.94K USD
Deferred Income Tax Expense (Benefit) 89.6K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 165 USD
Deferred Tax Assets, Operating Loss Carryforwards 5.05K USD -95.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 165 USD
Operating Lease, Payments 24.1K USD -67.7%
Additional Paid in Capital 6.44M USD +7966%
Current Federal Tax Expense (Benefit) 254K USD +108%
Depreciation, Depletion and Amortization 226K USD -37.7%